POSCO earnings, Revenue beat in Q2
Investing.com - POSCO reported on Tuesday second quarter {{erl-21260||earnings that beat analysts' forecasts and revenue that topped expectations. POSCO announced earnings per share of...
Strong Buy
or
Global Blood Therapeutics Inc News & Analysis
-
-
Sanofi Shares Slide After Trials of Potential Breast Cancer Drug Halted
By Scott Kanowsky Investing.com -- Sanofi SA (EPA:SASY) shares slid on Wednesday after the French drugmaker announced that it will halt trials of a new treatment for patients battling...
-
Analog Devices earnings, Revenue beat in Q3
Investing.com - Analog Devices (NASDAQ:ADI) reported on Wednesday third quarter {{erl-7869||earnings that beat analysts' forecasts and revenue that topped expectations. Analog Devices...
-
TJX earnings beat, Revenue misses in Q2
Investing.com - TJX (NYSE:TJX) reported on Wednesday second quarter {{erl-8227||earnings that beat analysts' forecasts and revenue that fell short of expectations. TJX announced earnings...
-
Indian Finance Minister Issues Warnings Regarding Crypto
The Indian finance minister suggested against using cryptocurrency.The law enforcement organization blocked the assets of two crypto exchanges.At a BJP Economic Cell event on Saturday,...
-
Pfizer Boosts Drug Pipeline with Global Blood Therapeutics Acquisition
American pharmaceutical giant Pfizer Inc. (NYSE: PFE) is boosting its hematology drug pipeline with the acquisition of Global Blood Therapeutics (NASDAQ: GBT) in a $5.4 billion all-cash...
-
Stock Market Today: Dow Ekes Out Gain After Losing Steam on Nvidia Slide
By Yasin Ebrahim Investing.com -- The Dow eked out a win Monday, after cutting the bulk of its intraday gains as Nvidia's profit warning kept tech stocks in the red. The Dow Jones...
-
S&P 500 Gives Up Gains as Nvidia Drags Down Tech
By Yasin Ebrahim Investing.com -- The S&P 500 gave up gains Monday, as investors weighed up a climb in consumer stocks and an Nvidia-led slump in tech after the chipmaker cut its...
-
Global Blood Therapeutics Shares Tick Higher After Pfizer Buy Agreed
By Scott Kanowsky Investing.com -- Pfizer Inc (NYSE:PFE) has agreed to acquire California-based Global Blood Therapeutics Inc (NASDAQ:GBT) for $5.4B including debt and net of cash...
-
Palantir, Tyson Foods, BioNTech Fall Premarket; Signify Health Rises
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Monday, August 8th. Please refresh for updates. Palantir (NYSE:PLTR) stock slumped 14.5% after the data analytics...
-
Dow Futures Up 140 Pts; Positive Corporate News Ahead of U.S. CPI
By Peter Nurse Investing.com -- U.S. stocks are seen opening higher Monday, continuing the recent positive tone generated by a generally healthy earnings season to date, ahead of the...
-
Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal
Biotechnology sector-related exchange traded funds continued to rally Friday on reports that Pfizer Inc. (NYSE: PFE) is looking to acquire Global Blood Therapeutics (NasdaqGS: GBT). On...
-
Pfizer in Global Blood Therapeutics Takeover Talks
By Sam Boughedda Pfizer (NYSE:PFE) is reportedly in talks to acquire Global Blood Therapeutics Inc (NASDAQ:GBT), according to a report by The Wall Street Journal Friday. The news...
-
Pfizer in advanced talks to buy Global Blood Therapeutics for $5 billion – WSJ
(Reuters) – Pfizer Inc is in advanced talks to buy drugmaker Global Blood Therapeutics for about $5 billion, the Wall Street Journal reported on Friday, citing people familiar with the...
-
Pharmaceutical Giants Eye Global Blood Therapeutics Takeover - Bloomberg
By Sam Boughedda Large pharmaceutical companies are reportedly eyeing a potential takeover deal for Global Blood Therapeutics (NASDAQ:GBT), according to a Bloomberg report Thursday. Citing...
-
Global Blood Therapeutics shares jump 34% after Bloomberg report about 'takeover interest'
Shares of Global Blood Therapeutics Inc. were up 34.4% in premarket trading on Thursday after Bloomberg reported that the company is "attracting takeover interest," citing people familiar...
-
After-Hours Movers: GBT Gains on Takeover Chatter, Lucid Falls Following Results
After-Hours Stock Movers: Global Blood Therapeutics (NASDAQ:GBT) 30% HIGHER; said to draw takeover interest - Bloomberg Yellow Corporation (NASDAQ:YELL) 27% HIGHER; {{erl-6458||reported Q2...
-
GBT Announces Participation at the Wedbush PacGrow Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will participate in a virtual fireside chat at...
-
MHRA Grants Marketing Authorization for GBT's Oxbryta® (voxelotor) for Use in Great Britain for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older
SOUTH SAN FRANCISCO, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that the Medicines and Healthcare products Regulatory...
-
Global Blood Therapeutics Tops Q1 EPS by 4c
Global Blood Therapeutics (NASDAQ:GBT) reported Q1 EPS of ($1.26), $0.04 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $55.16 million versus the consensus...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.38%
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Oil & Gas, Financials and Consumer Goods sectors propelled shares lower. At the close in NYSE, the Dow...
-
US STOCKS-Futures flat with focus on progress in trade talks
(For a live blog on the U.S. stock market, click LIVE/ or type LIVE/ in a news window.)* Futures: Dow up 0.02%, Nasdaq up 0.01%, S&P off 0.02%By Arjun PanchadarNov 26 (Reuters) - U.S. stock...
-
CORRECTED-UPDATE 2-Novartis sickle-cell drug gets U.S. FDA approval
(Corrects to clarify in second graph that patients will be infused by a healthcare provider)By John Miller and Carl O'DonnellNov 15 (Reuters) - Novartis AG NOVN.S on Friday won U.S....
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.13%
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Oil & Gas, Basic Materials and Technology sectors propelled shares higher. At the close in NYSE, the Dow...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.33%
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Healthcare, Consumer Services and Technology sectors propelled shares higher while losses in the Oil &...
-
US STOCKS-Wall St set to open flat ahead of Fed minutes
* Fed to release minutes at 2:00 p.m. ET * Dish rises on profit beat * Futures: Dow flat, S&P down 2.25 pts, Nasdaq down 0.5 pts (Adds details, comments, updates prices) By Yashaswini...
-
US STOCKS-Futures slip as investors await Fed minutes
* Futures down: Dow 10 pts, S&P 3.25 pts, Nasdaq 4 pts By Yashaswini Swamynathan Feb 22 (Reuters) - U.S. stock index futures dipped slightly on Wednesday as investors await details of...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
